Comparison of efficacy and safety of three induction chemotherapy regimens with gemcitabine plus cisplatin (GP), cisplatin plus fluorouracil (PF) and cisplatin plus capecitabine (PX) for locoregionally advanced previously untreated nasopharyngeal carcinoma: A pooled analysis of two prospective studies-Reference-Cited by-同舟云学术

Comparison of efficacy and safety of three induction chemotherapy regimens with gemcitabine plus cisplatin (GP), cisplatin plus fluorouracil (PF) and cisplatin plus capecitabine (PX) for locoregionally advanced previously untreated nasopharyngeal carcinoma: A pooled analysis of two prospective studies

Published:2021-03 Issue: Volume:114 Page:105158
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Chan Sik-Kwan,Chan Sum-Yin,Tong Chi-Chung^ORCID,Lam Ka-On^ORCID,Kwong Dora Lai-Wan,Leung To-Wai^ORCID,Luk Mai-Yee^ORCID,Lee Anne Wing-Mui,Choi Horace Cheuk-Wai,Lee Victor Ho-Fun

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference40 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. International Agency for Research on Cancer (IARC). Global cancer observatory. World Health Organization; 2020. https://gco.iarc.fr/.

3. Mao YP, Xie FY, Liu LZ, Sun Y, Li L, Tang LL, et al. Re-evaluation of 6th edition of AJCC staging system for nasopharyngeal carcinoma and proposed improvement based on magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2009;73(5):1326–34.

4. Management of nasopharyngeal carcinoma: current practice and future perspective;Lee;J Clin Oncol,2015

5. The next decade of clinical trials in locoregionally advanced nasopharyngeal carcinoma;Peng;Br J Radiol,2019

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing long-term efficacy and safety of GP versus TPF sequential chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis;BMC Cancer;2024-09-13

2. Prognostic Value of Parapharyngeal Involvement Subclassifications Divided by Parapharyngeal Muscles in Nasopharyngeal Carcinoma: A Study of 1752 Patients from Two Centers;2024-05-09

3. Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis;The Lancet Oncology;2023-06

4. Nomograms incorporating primary tumor response at mid‐radiotherapy to predict survival in locoregionally advanced nasopharyngeal carcinoma;Head & Neck;2023-05-19

5. Tumor volume reduction after induction chemotherapy with gemcitabine plus cisplatin in nasopharyngeal carcinoma;European Archives of Oto-Rhino-Laryngology;2022-12-27